Assessment of performance of manufacturing procedures in a unit for production of investigational anticancer agents, using a mixed effects analysis

Keyphrases

• Mixed Analysis 100%
• Anticancer Agents 100%
• Performance Assessment 100%
• Manufacturing Procedure 100%
• Product Quality 100%
• In Content 100%
• Content Uniformity 100%
• Quality Control Data 50%
• Approved Drugs 50%
• Tight 50%
• Filtration 50%
• Variability Sources 50%
• In-process 50%
• Drug Substance 50%
• Investigational Agents 50%
• Process Capability Index 50%
• Manufacturing Process 50%
• Generic Process 50%
• Aseptic Manufacturing 50%
• Product Development 50%
• Structural Bias 50%
• Batch-to-batch Variability 50%
• Specification Limits 50%
• Lyophilization 50%
• Filling Process 50%
• Batch-to-batch 50%

Engineering

• Product Quality 100%
• Quality Control 50%
• Influencing Parameter 50%
• Filling Process 50%
• Early Stage 50%
• Marginals 50%
• Process Capability Index 50%
• Product Manufacturing 50%
• Revealed Failure 50%
• Manufacturing Process 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticarcinogen 100%